HDL Master Class

held on September 29-30, 2011 in Prague, Czech Republic

Sep. 30, 2011

Modifying the functionality of HDL in future lipid management

The Master Class was a dynamic meeting with state of the art lectures, clinical debates, and practical workshops.
The meeting aimed to educate participants with state-of-the-art information about HDL cholesterol, and its role in current and future prevention of cardiovascular disease.

During this interactive programme an in-depth review was provided on the epidemiology, the metabolism and mechanisms of the protection that HDL cholesterol confers. Further, therapeutic strategies targeted to modify HDL cholesterol were discussed. The scientific programme was designed to set the stage for a new area of cardiovascular protection.

The educational objectives of this Master Class were:

To explore the role of HDL-C in atherosclerosis
To understand the importance of HDL functionality
To review the role of CETP inhibition in atherogenesis
To evaluate the effects of new HDL-C modifying therapies on the risk of cardiovascular events in CV risk patients
To understand the importance of HDL-C modification in patients at high CV risk, such as DM and metabolic syndrome
To understand the pharmacologic rationale and clinical impact of new clinical trial data on HDL-C modification for patients with atherosclerosis
To develop a consensus on practical guidelines for day-to-day lipid management of patients with atherosclerosis and CV risk